Blood Pressure and Glucose Lowering Diet for Taiwanese

NCT ID: NCT01364337

Last Updated: 2011-06-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-11-30

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prevalence rates of hypertension and diabetes are high in Taiwan. Little attention is given to evidence-based dietary therapy in Taiwan. Patients, after confirmed diagnosis, are mostly prescribed with medications without comprehensive instructions on dietary therapy. DASH diet has been proven to be an effective dietary approach to reduce blood pressure for hypertension patients in US. However, dietary difference and patient profiles across countries are evident. In addition, hypertensive patients are often combined with hyperglycemia. Carbohydrate burden of DASH diet may be higher than most dietitians desire. Therefore, the investigators in tend to design a Taiwanese DASH diet and a lower carbohydrate DASH diet and test their efficacy on both blood pressure and fasting glucose lowering.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DASH diet

Group Type ACTIVE_COMPARATOR

DASH diet

Intervention Type OTHER

DASH diet: A diet rich in whole grain, fruit and vegetable, low-fat dairy products, white meat and nuts; and lower of total fat and saturated fat.

lower carbohydrate DASH diet

Group Type ACTIVE_COMPARATOR

lower carbohydrate DASH diet

Intervention Type OTHER

lower carbohydrate DASH diet: A DASH diet with lower carbohydrate percentage

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

DASH diet

DASH diet: A diet rich in whole grain, fruit and vegetable, low-fat dairy products, white meat and nuts; and lower of total fat and saturated fat.

Intervention Type OTHER

lower carbohydrate DASH diet

lower carbohydrate DASH diet: A DASH diet with lower carbohydrate percentage

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 20-65 years, weight 50-80 kg(±5kg)
* Two blood pressure readings and fasting blood glucose measurements:

1. fasting blood glucose of 100-125 ml/dL and not using antidiabetic medication.
2. systolic blood pressure of 130-159 mmHg or diastolic blood pressure of 85-99 mmHg and not using antihypertensive medication.

Exclusion Criteria

* (a) taking blood glucose lowering, antihypertensive or oral steroid medications.

(b) history of stroke, cardiovascular disease, abnormal liver function, cancer, stomach ulcer, inflammatory bowel disease or other chronic diseases that will influence the diet of participants.

(c) Major surgery in the past year or about to undergo major surgery.

(d) Is the holder of a major illness card.

(e) Takes antipsychotics.

(f) Harmful drinker (more than 14 drinks per week)

(g) Has food allergies or food intolerance.

(h) Pregnant or breastfeeding.

(i) Unwilling to cease intake of vitamin or mineral supplements or antacids containing magnesium or calcium for the duration of the study.

(j) Other medications or physiological states influencing the absorption of nutrients.

(k) Other individuals deemed unsuitable to participate in the intervention by their treating physician.
Minimum Eligible Age

20 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

Sponsor Role collaborator

National Health Research Institutes, Taiwan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

National Health Research Institutes, Taiwan

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wen-Han Pan, Ph. D.

Role: PRINCIPAL_INVESTIGATOR

National Health Research Institutes, Taiwan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Health Research Institutes

Miaoli County, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EC0990602-E

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.